Brief: Interpace Biosciences Q3 Revenue USD 9.078 Million

Interpace Biosciences

08/11/2023 20:29

Nov 08 (Reuters) - Interpace Biosciences Q3 operating expenses USD 4.97
million.
* Q3 net income USD -614 thousand
* Q3 gross profit USD 4.954 million
* Q3 operating income USD -16 thousand